Announced
Financials
Sources
Tags
South Korea
pharmaceutical ingredient distributor
Friendly
Single Bidder
Pending
Private
Pharmaceuticals
Acquisition
Synopsis
IMCD, a leading distributor of speciality chemicals and food ingredients, agreed to acquire 57% of the outstanding shares of South Korean based pharmaceutical ingredient distributor Whawon Pharm. In 2018, the company generated a revenue of KRW 57bn ($49m) with 54 employees. "MCD is an ideal partner for Whawon as they share a similar business culture and have a highly dedicated global pharmaceutical presence. We look forward to utilising their technical capability to further develop growth for our customers and suppliers," Young-Hee Won, Whawon CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.